![António Bernadino Guimaraes Parada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
António Bernadino Guimaraes Parada
Chief Executive Officer at IONTAS Ltd. (United Kingdom)
Profile
António Bernadino Guimaraes Parada is the founder of Fairjourney Biologics SA, where he holds the position of Chairman & Chief Executive Officer since 2012.
He is also the founder of Biocodex Incubação de Empresas de Ciências da Vida SA. Currently, he is the Chief Executive Officer at IONTAS Ltd.
(United Kingdom) since 2020.
António Bernadino Guimaraes Parada active positions
Companies | Position | Start |
---|---|---|
IONTAS Ltd. (United Kingdom)
![]() IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Part of Fairjourney Biologics SA, IONTAS Ltd. is a British company that provides antibody discovery services. The company is based in Cambridge, UK. The company was founded by John McCafferty. António Bernadino Guimaraes Parada has been the CEO of the company since 2020. IONTAS Ltd. (United Kingdom) was acquired by Fairjourney Biologics SA on May 13, 2020. | Chief Executive Officer | 30/04/2020 |
Fairjourney Biologics SA
![]() Fairjourney Biologics SA BiotechnologyHealth Technology Fairjourney Biologics SA is a biologics contract research organization that provides integrated services across antibody discovery, engineering, and production to biopharma. The Portuguese company operates a flexible, customer-oriented ‘ one-stop shop ’ approach to biologics development focused on quality, reliability, and partnership. Fairjourney Biologics has successfully completed more than 500 projects for over 100 customers across big pharma and leading biotech companies to date. The company's innovative mammalian display platform enables full-length antibodies to be expressed in the context of a mammalian cell, allowing selection based on function, stability, expression, and developability. The company has grown to over 130 highly technically skilled employees today and has subsidiaries in the United Kingdom. Fairjourney Biologics was founded in 2012 by António Bernadino Guimaraes Parada and Maria Gonzalez Pajuelo and is headquartered in Porto, PT. António Bernadino Guimaraes Parada has been the CEO since 2012. | Chief Executive Officer | 31/12/2011 |
Former positions of António Bernadino Guimaraes Parada
Companies | Position | End |
---|---|---|
Biocodex Incubação de Empresas de Ciências da Vida SA
![]() Biocodex Incubação de Empresas de Ciências da Vida SA Financial ConglomeratesFinance Biocodex Incubação de Empresas de Ciências da Vida SA invests in and develops biotechnology research businesses and programs. The company was founded on July 29, 2002 and is headquartered in Porto, Portugal. | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Biocodex Incubação de Empresas de Ciências da Vida SA
![]() Biocodex Incubação de Empresas de Ciências da Vida SA Financial ConglomeratesFinance Biocodex Incubação de Empresas de Ciências da Vida SA invests in and develops biotechnology research businesses and programs. The company was founded on July 29, 2002 and is headquartered in Porto, Portugal. | Finance |
IONTAS Ltd. (United Kingdom)
![]() IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Part of Fairjourney Biologics SA, IONTAS Ltd. is a British company that provides antibody discovery services. The company is based in Cambridge, UK. The company was founded by John McCafferty. António Bernadino Guimaraes Parada has been the CEO of the company since 2020. IONTAS Ltd. (United Kingdom) was acquired by Fairjourney Biologics SA on May 13, 2020. | Health Technology |
Fairjourney Biologics SA
![]() Fairjourney Biologics SA BiotechnologyHealth Technology Fairjourney Biologics SA is a biologics contract research organization that provides integrated services across antibody discovery, engineering, and production to biopharma. The Portuguese company operates a flexible, customer-oriented ‘ one-stop shop ’ approach to biologics development focused on quality, reliability, and partnership. Fairjourney Biologics has successfully completed more than 500 projects for over 100 customers across big pharma and leading biotech companies to date. The company's innovative mammalian display platform enables full-length antibodies to be expressed in the context of a mammalian cell, allowing selection based on function, stability, expression, and developability. The company has grown to over 130 highly technically skilled employees today and has subsidiaries in the United Kingdom. Fairjourney Biologics was founded in 2012 by António Bernadino Guimaraes Parada and Maria Gonzalez Pajuelo and is headquartered in Porto, PT. António Bernadino Guimaraes Parada has been the CEO since 2012. | Health Technology |
- Stock Market
- Insiders
- António Bernadino Guimaraes Parada